Media, PA, United States of America

Lee-yuan Liu-Chen

This inventor holds 2 USPTO granted patents. Top assignees: The Mclean Hospital Corporation, Temple University. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee-yuan Liu-Chen. Retrieved from https://idiyas.com/inventor/lee-yuan-liu-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lee-yuan Liu-Chen: Innovator in Salvinorin Research

Introduction

Lee-yuan Liu-Chen is a notable inventor based in Media, PA (US). He has made significant contributions to the field of pharmacology, particularly through his research on salvinorin derivatives. With a total of 2 patents, his work focuses on innovative methods for treating mood disorders.

Latest Patents

Liu-Chen's latest patents include groundbreaking inventions related to salvinorin compositions that are selective for kappa opioid receptors. These inventions detail methods of treating mania by utilizing a selective kappa receptor agonist. Additionally, they explore methods for addressing mood disorders, such as depressive and manic disorders, using these salvinorin compositions.

Career Highlights

Throughout his career, Liu-Chen has worked with esteemed organizations, including the McLean Hospital Corporation and Temple University. His research has garnered attention for its potential impact on mental health treatment.

Collaborations

Liu-Chen has collaborated with notable colleagues, including William A. Carlezon and Bruce M. Cohen. Their joint efforts have contributed to advancing the understanding of salvinorin's therapeutic applications.

Conclusion

Lee-yuan Liu-Chen's innovative work in salvinorin research highlights his commitment to improving mental health treatment. His contributions through patents and collaborations continue to pave the way for future advancements in this important field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…